We developed a multiplex PCR-based reverse line blot (mPCR/RLB) assay to identify 50 uncommon pneumococcal serotypes. In combination with a previously described mPCR/RLB assay (3), all 90 pneumococcal serotypes can be identified individually (32 serotypes) or, because of predictable cross-reactions, to within small groups of two to five related serotypes (58 serotypes), which can be distinguished using serotypespecific antisera.
Recently, we described a multiplex PCR-based reverse line blot (mPCR/RLB) hybridization assay to identify 40 Streptococcus pneumoniae serotypes, including the 23 represented in the polysaccharide vaccine and 17 others that show reproducible cross-reactions (3) . In this study, we designed one pair of specific primers and one probe for each of the remaining 50 serotypes to allow provisional identification of all 90 known serotypes by mPCR/RLB (5) . The primer and probe sequences were based on recently published full cps gene cluster sequences of all 90 pneumococcal serotypes (1) and on other sequences available in GenBank (4, 7) .
Twenty sets of serotype-specific primer pairs and probes were designed; the remaining 30 serotypes shared identical or very similar wzy sequences with one or two others in the same or closely related serogroups, as follows: 7B/7C/40, 10F/10C, 11B/11C, 15F/15A, 19B/19C, 24F/24A/24B, 25F/25A/38, 28F/ 28A, 32F/32A, 33B/33D, 35F/47F, 35A/35C/42, and 41F/41A. The primers and probes used in this assay are shown in Table 1 .
Probes and primers were designed with similar physical characteristics to allow simultaneous amplification and hybridization in a multiplex reaction (5) and were synthesized by Sigma-Aldrich (Sydney, Australia). Primers were biotinylated at the 5Ј end, and probes had a 5Ј amine group (5) . DNA extraction (6) and RLB hybridization were performed as previously described (5) . mPCR was performed according to the QIAGEN Hotstar Taq polymerase kit instructions (5) under the following conditions: 95°C for 15 min; 35 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min; 72°C for 10 min; and a hold at 22°C. The 34-primer-pair mPCR mixture was prepared to contain the following: 2 l template DNA, 0.075 l of each forward (100 pmol l Ϫ1 ) and reverse (100 pmol l Ϫ1 ) primer, 2.4 l deoxynucleoside triphosphates (2.5 mM of each deoxynucleoside triphosphate), 3 l 10ϫ PCR buffer, 4.2 l 25 mM MgCl 2 (final concentration, 5 mM), 0.2 l QIAGEN Hotstar Taq polymerase (5 units l Ϫ1 ), and water to 30 l. Preliminary testing of reference strains of all 90 serotypes (Statens Serum Institut, Copenhagen, Denmark) showed that all 50 target serotypes (and none of the other 40) were amplified and hybridized by the mPCR/RLB system; 20 serotypes reacted only with the corresponding primers and probe, and 30 exhibited the predicted cross-reactions (Table 1 ; Fig. 1 ).
The method was further evaluated using 173 previously studied (4, 7) clinical isolates from China, Australia, and Canada, which included one to four isolates of all pneumococcal serotypes except for 10C, 11F, 23B, 25A, and 33D (for which clinical isolates were not available). They were tested by mPCR/RLB without knowledge of the serotype. Sixty-eight isolates belonging to 1 of 40 serotypes identified by our original mPCR/RLB assay were not amplified. One nonserotypable isolate was also not amplified by either the previous (3) or new mPCR, although it was confirmed to be S. pneumoniae by species-specific PCR and phenotypic characteristics. This result suggests that this isolate either contains a significant cps deletion or mutation (8) or belongs to a novel serotype (10) .
Forty-four isolates were identified as being of individual serotypes corresponding with those identified by conventional serotyping, and 59 were identified as being one of a group of two or three related serotypes which, with one exception, included the serotype identified by conventional serotyping (Table 2).
The exception was an isolate from China, which was identified as serotype 33B/33D by mPCR/RLB and as serotype 33C by conventional serotyping. Both methods were repeated and the initial (discrepant) results confirmed. Single PCR was positive with 33B/33D-specific and negative with 33C-specific primers. Sequencing of a portion of wzy of this isolate showed that it was different from that of any known serotype (1, 7) but more closely related to that of 33C than to that of 33B/33D. Although the discrepancy between molecular and immunological serotype identifications remained unresolved, our results suggest that wzy is not the only determinant of antigenic specificity (3) . Further investigation of this isolate is in progress.
Finally, the mPCR/RLB assay was used to test 152 clinical Table 1 for descriptions and specificities of the probes listed on the left). Conventional serotype-mPCR/RLB results for the isolates shown, from left to right, are 43, 7B, 9A,* 9L,* 9V,* 19B, 11B, 11C, 12A,* 15F, 16F, 17A, 18F,* 19B, 19C, 21, 24F, 24A, 24B, 11B, 27, 28F, 28A, 32F, 32A, 33A,* 33B, 33B, 33F,* 35C, 36, 37,* 39, 40, 41F, 41A, 44,* 43, 7B, 45, 46,* 47F, and 47A. Isolates marked with asterisks belong to one of 40 serotypes identified by our original mPCR/RLB assay (3) and were not amplified in this assay. a S, sense; A, antisense; b, biotin-labeled primer (primers were biotin labeled at the 5Ј end); p, probe (probes were 5Ј end labeled with a C-6 amine); n, non-biotin-labeled primer.
b Based on published sequence data for the whole cps gene cluster, it was not possible to design primers/probes that could distinguish some individual serotypes from one to three closely related ones, usually (but not always) belonging to the same serogroup. (5) by adding 2 l of proteinase K (20 mg/ml; Sigma, Australia) to tubes before heating them at 100°C for 10 min. Two isolates that still were not amplified had been identified, using antisera, as serotypes 11F and 16A. Conventional serotyping was repeated and showed that they belonged to serotypes 11A and 18C, respectively (not represented in the current mPCR/RLB system). Two isolates, previously identified as serotypes 35A and 29, were identified by mPCR/RLB as 35F and 35B, respectively. Retesting with antisera confirmed the mPCR/RLB results. Seventy-three isolates were identified by mPCR/RLB as single serotypes corresponding with those of conventional serotyping; 75 isolates gave positive results with probes cross-reacting with two or three related serotypes, which included the serotypes identified by conventional serotyping. The mPCR/ RLB-predicted serotypes for these 152 isolates are shown in Table 3 .
Because serotype-specific targets within cps gene clusters are not always available, this mPCR/RLB assay is less discriminatory-although more objective and reproducible-than conventional serotyping (2, 4) . In combination with our previous mPCR/RLB assay (3), it can identify 32 serotypes precisely and 58 as belonging to one of two to five related serotypes. This is the first report of a practical molecular assay that can predict all 90 serotypes without sequencing. Potentially, it can be used to identify multiple serotypes directly in clinical (including culture-negative) specimens. It could be adapted to other platforms, such as "liquid" molecular beacons (9) and solid microarrays (12) .
For routine serotyping of pure pneumococcal cultures, our first mPCR/RLB assay (identification of 40 serotypes) would be used initially to identify the most prevalent serotypes Negative a One isolate from China, which was identified as 33B/33D by single PCR and mPCR/RLB, was shown to be 33C by using serotype-specific antiserum.
b This isolate was amplified and hybridized by S. pneumoniae-specific primers and probes (targeting lytA) and had optochin susceptibility and bile solubility. a Serotypes in parentheses are corrected serotypes after retesting by conventional serotyping; these serotypes are not included in the new mPCR/RLB assay.
b One isolate initially identified as serotype 35A was found to be 35F upon being retested.
c One isolate initially identified as serotype 29 was found to be 35B upon being retested.
(Ͼ95% of invasive isolates, based on unpublished data from the NSW Pneumococcal Reference Laboratory) (3). The current assay would then be needed, infrequently, to identify the small proportion of isolates belonging to less-common serotypes.
